Clinical Trial Update: An Exploratory Study to Investigate the Effect of FE 999302 When Given Together With Follitropin Delta During Controlled Ovarian Stimulation [Phase 1]

View source ↗

Summary

Phase 1 exploratory trial evaluating FE 999302 in combination with Follitropin Delta during controlled ovarian stimulation has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infertility

Drugs mentioned

• FE 999302
• Follitropin Delta (follicle-stimulating hormone delta)

Snippet

Sponsor: Ferring Pharmaceuticals | Conditions: Fertility | Phase 1 | Status: TERMINATED